Lipocine (LPCN) Other Non-Current Liabilities (2012 - 2024)
Lipocine's Other Non-Current Liabilities came in at $3,586 for Q3 2024, down 87.8% from $29,440 a year earlier and down 97.5% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Other Non-Current Liabilities (2012 - 2024) Analysis & Trends
At the end of FY2023, Lipocine's Other Non-Current Liabilities was $17,166, down 92.5% from FY2022.
- Other Non-Current Liabilities has declined in each of the last four years, with a four-year compound annual growth rate of -75.3% (FY2019 to FY2023).
- Going back by year, Other Non-Current Liabilities was $229,856 in FY2022 (-71.1%), $795,796 in FY2021 (-32.0%), $1.17 million in FY2020 (-74.5%) and $4.59 million in FY2019.
- The Q3 2024 figure represents the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2012.
- Year-over-year, Other Non-Current Liabilities increased in 1 of the last eight quarters, with an average decline of 66.5%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2024 (growth of 35.9%), and the weakest in Q4 2023 (a decline of 92.5%).
- Business Quant data shows LPCN's Other Non-Current Liabilities at $141,668 (Q2 2024), $57,238 (Q1 2024) and $17,166 (Q4 2023) in the three quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 3,586.00 |
| Jun 30, 2024 | 141,668.00 |
| Mar 31, 2024 | 57,238.00 |
| Dec 31, 2023 | 17,166.00 |
| Sep 30, 2023 | 29,440.00 |
| Jun 30, 2023 | 104,267.00 |
| Mar 31, 2023 | 131,722.00 |
| Dec 31, 2022 | 229,856.00 |
| Sep 30, 2022 | 264,099.00 |
| Jun 30, 2022 | 590,339.00 |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 795,796.00 |
| Sep 30, 2021 | 645,478.00 |
| Jun 30, 2021 | 1.50 Mn |
| Mar 31, 2021 | 1.35 Mn |
| Dec 31, 2020 | 1.17 Mn |
| Sep 30, 2020 | 1.30 Mn |
| Jun 30, 2020 | 2.17 Mn |
| Mar 31, 2020 | 5.69 Mn |
| Dec 31, 2019 | 4.59 Mn |
API Access
Lipocine Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();